Gennex Laboratories soars on getting WHO-GMP Certificate from Government of Telangana
Gennex Laboratories is currently trading at Rs. 7.00, up by 0.37 points or 5.58% from its previous closing of Rs. 6.63 on the BSE.
The scrip opened at Rs. 6.66 and has touched a high and low of Rs. 7.15 and Rs. 6.12 respectively. So far 521555 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 1 has touched a 52 week high of Rs. 9.10 on 26-Dec-2022 and a 52 week low of Rs. 4.81 on 24-Feb-2023.
Last one week high and low of the scrip stood at Rs. 7.15 and Rs. 6.12 respectively. The current market cap of the company is Rs. 126.20 crore.
The promoters holding in the company stood at 23.38%, while Non-Institutions held 76.62% stake in the company.
Gennex Laboratories has received World Health Organization Goods Manufacturing Practice (WHO-GMP) Certificate from the Drug Control Administration, Government of Telangana. The company has received WHO-GMP Certificate for a period of three years from the date of issue which is valid up to July 5, 2026.
Gennex Laboratories is engaged in the manufacture and export of bulk drugs and intermediates.
